Author: Reffelmann Thorsten Kieback Arne Kloner Robert A
Publisher: Informa Healthcare
ISSN: 1474-0338
Source: Expert Opinion on Drug Safety, Vol.7, Iss.1, 2008-01, pp. : 43-52
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Drugs, Vol. 63, Iss. 20, 2003-01 ,pp. :
The cardiovascular safety of rosiglitazone
By Ajjan Ramzi A Grant Peter J
Expert Opinion on Drug Safety, Vol. 7, Iss. 4, 2008-07 ,pp. :
Cardiovascular Safety of Sildenafil
Drug Safety, Vol. 26, Iss. 7, 2003-01 ,pp. :
Controversy about the Cardiovascular Safety of Sibutramine
Drug Safety, Vol. 33, Iss. 7, 2010-07 ,pp. :
Rosiglitazone: accusations over cardiovascular safety
Reactions Weekly, Vol. 1, Iss. 1290, 2010-01 ,pp. :